New here, starting an incredible business

[FinalSpark]

Hello,

I am the co-founder of 2 companies, AlpVision and FinalSpark, in Switzerland.
The former was founded about 20 years ago and is a great financial success.
The latter started 3 years ago (fundamental AI research) and is not looking at making any money actually
However, we also started last year a really wild activity, bioserver.net, that I will briefly present in the progress section of the forum.

Have fun,

Fred.

 

Dislike ads? Remove them and support the forum: Subscribe to Fastlane Insiders.

[The Autobahn]

Cool is this ETH university Spinoff ?

 

[FinalSpark]

Cool is this ETH university Spinoff ?

No, it’a spinoff of AlpVision... which was a spinoff of EPFL...

 

[MJ DeMarco]

Welcome aboard.

 

Dislike ads? Remove them and support the forum: Subscribe to Fastlane Insiders.

[George Appiah]

Welcome to the Fastlane community, my new friend.

Looking forward to your progress thread!

 

[FinalSpark]

We just made our first Press Release for BioServer.net disruptive innovation for artificial intelligence!

AlpVision to Offer the First Online Biological Neural Networks (BNN) Servers Subscription Services for Artificial Intelligence Researchers
VEVEY, Switzerland, June 12, 2019 /PRNewswire/
AlpVision SA, a pioneering information and communication technology company and a global leader in advanced signal processing applications, announces at the AI summit in London the release plan of bioserver.net, a new cloud computing service based on Biological Neural Networks (BNN).

Neurosphere and adherent neural cells on a CMOS MEA.
By integrating neural cell culture wetware, CMOS MEAs hardware, signal processing software and internet frontend technologies, bioserver.net will offer artificial intelligence researchers a remote access to living, low-energy consumption computing units of real neural networks as opposed to the silicon-based artificial neural networks. “BNN cultures have long been used by the pharmaceutical industry in clinical pharmacology during drug development using dedicated cell culture protocols to grow neural networks and maintain them for several months, possibly several years. The recent development of high-density CMOS MEAs interfacing now enables high throughput of both stimulation and read-out signals in direct connection to the living BNNs at increased resolution, both spatial through thousands of electrodes and temporal through signal sampling at several kHz. “This represents an unprecedented opportunity to engineer biological processing systems integrating wetware components. We envision that BNNs can bring a inherent neuron processing capability at a much lower power consumption cost than their silicon equivalents. Keep in mind the brain only consumes about 20W to perform its high level complex cognitive tasks,” said Fred D. Jordan, PhD, AlpVision’s co-founder and Chief Executive Officer.
In addition to facilitating remote access to monitoring BNN cultures for AI researchers without the need to build and maintain a wetlab facility, the bioserver.net frontend API will also offer various remote programming options for the backend computers in charge with controlling the BNNs in real time, similar to a remote desktop application. “In order to conduct their research, AI experts need to exploit the computing and learning capabilities of the BNNs with more advanced signal processing. Thanks to the bioserver.net programming tools, the high throughput MEA signals (of up to several gigabytes per minute) may thus be locally pre-computed, post-processed and filtered according to the individual needs of the master application. It is even possible to operate deep learning algorithms in the end-to-end system architecture over the BNN layer,” said Martin Kutter, PhD, AlpVision co-founder and President.
The bioserver.net services will be available by end 2019 for a monthly subscription, with access to networks of 50000 to 100000 neurons as a start.